Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. West Pharmaceutical Services, Inc.

15.6% sales growth and 19.44% return on equity

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.

West Pharmaceutical Services, Inc.’s sales growth this year is expected to be 14.9% and 11.1% for next year.

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 2.04B for the twelve trailing months.

West Pharmaceutical Services, Inc.’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the ongoing quarter and the next is 36.6% and 18.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.44%.

West Pharmaceutical Services, Inc.’s Stock Yearly Top and Bottom Value

West Pharmaceutical Services, Inc.’s stock is valued at $276.09 at 19:22 EST, under its 52-week high of $305.00 and way higher than its 52-week low of $124.53.

West Pharmaceutical Services, Inc.’s Moving Average

West Pharmaceutical Services, Inc.’s value is under its 50-day moving average of $277.11 and higher than its 200-day moving average of $264.04.

2. Merchants Bancorp

33.2% sales growth and 21.75% return on equity

Merchants Bancorp operates as the diversified bank holding company in the United States.

Merchants Bancorp’s sales growth this year is anticipated to be 95.1% and a negative 7.8% for next year.

Year-on-year quarterly revenue growth grew by 138.9%, now sitting on 290.26M for the twelve trailing months.

Merchants Bancorp’s sales growth for the next quarter is 33.2%. The company’s growth estimates for the current quarter and the next is 62% and 56.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.75%.

Merchants Bancorp’s Stock Yearly Top and Bottom Value

Merchants Bancorp’s stock is valued at $28.94 at 19:22 EST, under its 52-week high of $29.45 and way higher than its 52-week low of $12.37.

Merchants Bancorp’s Moving Average

Merchants Bancorp’s value is way above its 50-day moving average of $25.53 and way above its 200-day moving average of $20.70.

3. PennyMac Financial Services, Inc.

8.6% sales growth and 54.65% return on equity

PennyMac Financial Services, Inc., through its subsidiaries, engages in the mortgage banking and investment management activities in the United States.

PennyMac Financial Services, Inc.’s sales growth this year is anticipated to be 146.9% and a negative 18% for next year.

Year-on-year quarterly revenue growth grew by 47.1%, now sitting on 4.06B for the twelve trailing months.

PennyMac Financial Services, Inc.’s sales growth for the next quarter is 8.6%. The company’s growth estimates for the present quarter and the next is 203.7% and 6.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.65%.

PennyMac Financial Services, Inc.’s Stock Yearly Top and Bottom Value

PennyMac Financial Services, Inc.’s stock is valued at $64.24 at 19:22 EST, under its 52-week high of $67.77 and way above its 52-week low of $13.14.

PennyMac Financial Services, Inc.’s Moving Average

PennyMac Financial Services, Inc.’s value is way higher than its 50-day moving average of $57.72 and way above its 200-day moving average of $51.73.

4. Ericsson

17.8% sales growth and 18.65% return on equity

Telefonaktiebolaget LM Ericsson (publ) provides information and communications technology solutions for service providers.

Ericsson’s sales growth this year is expected to be 8.1% and 6.4% for next year.

Year-on-year quarterly revenue growth grew by 0.6%, now sitting on N/A for the twelve trailing months.

Ericsson’s sales growth for the next quarter is 17.8%. The company’s growth estimates for the ongoing quarter and the next is 61.5% and 75%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.65%.

Ericsson’s Stock Yearly Top and Bottom Value

Ericsson’s stock is valued at $11.66 at 19:22 EST, under its 52-week high of $12.61 and way above its 52-week low of $6.15.

Ericsson’s Moving Average

Ericsson’s value is below its 50-day moving average of $12.00 and above its 200-day moving average of $10.94.

Previous days news about Ericsson

Veoneer's chief technology officer will leave the company to pursue new career opportunity. According to Business Insider on Thu Dec 17, "Mr. Batra joined Veoneer in November 2018 from Ericsson and will leave in January to return to the telecommunications industry as Chief Strategy & Technology Officer for Nokia Corporation and will relocate to the United States. "

Huawei eyes Ethiopia growth as telecoms industry opens up. According to Bloomberg Quint on Thu Dec 17, "In Africa, where it is a top vendor ahead of rivals such as Nokia Oyj and Ericsson AB, several leaders have defended the company. "

Why telecom firms are among 2021’s top european m&a targets. According to Bloomberg Quint on Fri Dec 18, "Finland’s Nokia has also been the subject of similar speculation, as the firm has come under pressure from competitors Ericsson AB and China’s Huawei Technologies Co. in the race to win share in the 5G market."

5. Citizens & Northern Corp

37.6% sales growth and 6.64% return on equity

Citizens & Northern Corporation operates as the bank holding company for Citizens & Northern Bank that provides a range of banking and mortgage services to individual and corporate customers in North Central Pennsylvania and Southern New York.

Citizens & Northern Corp’s sales growth this year is anticipated to be 22.6% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 34.5%, now sitting on 81.03M for the twelve trailing months.

Citizens & Northern Corp’s sales growth for the next quarter is 37.6%. The company’s growth estimates for the current quarter and the next is a negative 15.2% and 2.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.64%.

Citizens & Northern Corp’s Stock Yearly Top and Bottom Value

Citizens & Northern Corp’s stock is valued at $0.00 at 19:22 EST, under its 52-week low of $14.92.

Citizens & Northern Corp’s Moving Average

Citizens & Northern Corp’s worth is below its 50-day moving average of $18.51 and below its 200-day moving average of $18.28.

6. Semler Scientific, Inc.

20.9% sales growth and 63.32% return on equity

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.

Semler Scientific, Inc.’s sales growth this year is anticipated to be 13.3% and 44.5% for next year.

Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 35.68M for the twelve trailing months.

Semler Scientific, Inc.’s sales growth for the next quarter is 20.9%. The company’s growth estimates for the current quarter and the next is 16.2% and 30.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.32%.

Semler Scientific, Inc.’s Stock Yearly Top and Bottom Value

Semler Scientific, Inc.’s stock is valued at $84.79 at 19:22 EST, below its 52-week high of $85.00 and way above its 52-week low of $30.00.

Semler Scientific, Inc.’s Moving Average

Semler Scientific, Inc.’s value is way above its 50-day moving average of $70.95 and way above its 200-day moving average of $55.61.

7. Provident Bancorp, Inc.

14.8% sales growth and 5.45% return on equity

Provident Bancorp, Inc. operates as a holding company for The Provident Bank that provides various financial services to individuals and small businesses in the United States.

Provident Bancorp, Inc.’s sales growth this year is expected to be 23% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 47.86M for the twelve trailing months.

Provident Bancorp, Inc.’s sales growth for the next quarter is 14.8%. The company’s growth estimates for the current quarter and the next is 35.7% and 57.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.45%.

Provident Bancorp, Inc.’s Stock Yearly Top and Bottom Value

Provident Bancorp, Inc.’s stock is valued at $11.93 at 19:22 EST, under its 52-week high of $12.91 and way above its 52-week low of $7.21.

Provident Bancorp, Inc.’s Moving Average

Provident Bancorp, Inc.’s worth is way above its 50-day moving average of $10.07 and way above its 200-day moving average of $8.58.

8. Ameris Bancorp

25% sales growth and 9.19% return on equity

Ameris Bancorp operates as the bank holding company for Ameris Bank that provides banking services to retail and commercial customers primarily in Georgia, Alabama, Florida, and South Carolina.

Ameris Bancorp’s sales growth this year is anticipated to be 57.1% and a negative 10.5% for next year.

Year-on-year quarterly revenue growth grew by 42.7%, now sitting on 895.64M for the twelve trailing months.

Ameris Bancorp’s sales growth for the next quarter is 25%. The company’s growth estimates for the ongoing quarter and the next is 15.6% and 228.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.19%.

Ameris Bancorp’s Stock Yearly Top and Bottom Value

Ameris Bancorp’s stock is valued at $37.62 at 19:22 EST, way under its 52-week high of $44.90 and way higher than its 52-week low of $17.12.

Ameris Bancorp’s Moving Average

Ameris Bancorp’s value is way higher than its 50-day moving average of $33.35 and way higher than its 200-day moving average of $26.46.

LEAVE A REPLY

Please enter your comment!
Please enter your name here